## Abstract The original article to which this Erratum refers was published in __Movement__ Disorders, Volume 19, Issue 12, pages 1451–1453. In the brief report by Capecci and colleagues that appears in this issue of __Movement__ Disorders, the authors mistakenly refer to the patient's 30‐year‐old
Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the Parkin gene
✍ Scribed by Marianna Capecci; Luca Passamonti; Ferdinanda Annesi; Grazia Annesi; Michele Bellesi; Innocenza Claudia Cirò Candiano; Riccardo Ricciuti; Maurizio Iacoangeli; Massimo Scerrati; Mario Zappia; Patrizia Tarantino; Elvira Valeria De Marco; Donatella Civitelli; Sara Carrideo; Leandro Provinciali; Maria Gabriella Ceravolo; Aldo Quattrone
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 53 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Chronic subthalamic nucleus deep brain stimulation (STN‐DBS) is an efficacious treatment for idiopathic Parkinson's disease (PD) that cannot be further improved by medical therapy. We present a case of an individual with juvenile parkinsonism caused by homozygous deletion of exon 3 in the parkin gene with disabling long‐term side‐effects from levodopa who underwent bilateral STN neuromodulation. Parkin‐linked parkinsonism may show clinical features different from sporadic PD, yet it shares levodopa responsiveness. Because levodopa responsiveness is a predictor of STN‐DBS efficacy, we argued that this kind of surgical approach might be efficacious in hereditary parkin‐linked juvenile parkinsonism. We evaluated clinical and functional assessment before and 12 months after surgery. The results showed that the Unified Parkinson Disease Rating Scales Motor score improved by 84% in our patient, the levodopa equivalent daily dose medication (LEDD) was reduced by 66%, and, finally, disabling and severe dyskinesias disappeared. © 2004 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The role of subthalamic nucleus (STN) deep brain stimulation (DBS) is well established in Parkinson's disease, but experience with STN DBS in other movement disorders is limited. We report on a patient with medically refractory cervical dystonia and essential tremor resulting in dystoni
The safety and efficacy of subthalamic nucleus (STN) deep brain stimulation (DBS) in patients who have had a previous unilateral pallidotomy is not clear. We identified 10 patients (9 male) at the Baylor College of Medicine Parkinson's Disease Center who underwent STN DBS after prior unilateral pall
## Abstract To determine whether the degree to which a patient with Parkinson's disease expects therapeutic benefit from subthalamic nucleus–deep brain stimulation (STN‐DBS) influences the magnitude of his or her improved motor response, 10 patients with idiopathic Parkinson's and bilateral STN‐DBS
## Abstract Tardive dystonia usually occurs with a delay after neuroleptic exposure in patients with major psychosis. A subgroup of patients, however, is given such medication for “mild depression” or “neurasthenia.” Tardive dystonia, in general, may respond favorably to pallidal deep brain stimula